Overview

Enfusion brings portfolio operations, trading, compliance, risk, and reporting into a single platform for hedge funds and asset managers. It is best suited to investment firms coordinating complex strategies across asset classes; custom pricing and the need to provide the equipment and connectivity make it a poor fit for individuals or teams looking for a ready-priced tool.

Support for long/short equity, global macro, multi-strategy, event-driven, credit, emerging markets, and multi-asset strategies gives it broad reach. Clearwater says more than 1,000 hedge funds and asset managers across more than 30 countries use the platform. It supports both asset coverage categories, investor reporting, and multiple currencies.

For category browsing, see Portfolio Management Software and Investment Accounting Software.

Key features

Portfolio management and execution

Real-time positions, P&L, analytics, and factor exposure give portfolio teams a live view of holdings and risk. Orders can be generated from model changes or target-exposure adjustments, helping connect portfolio decisions to execution. The native order and execution management system supports equities, fixed income, options, futures, FX, swaps, and other instruments.

FIX connections reach more than 300 liquidity sources, while automated prime broker and custodian delivery can reduce operational handoffs. That breadth is useful for firms with varied trading needs, though it also makes Enfusion more platform than a focused portfolio tracker.

Compliance and data

Pre-trade checks run as orders are created and can apply firm, client, and regulatory rules. Firms can create custom rules and set a response as a warning, note, or hard block, allowing compliance teams to match controls to the seriousness of a breach. IBOR and ABOR share one database, supported by a security master of more than four million instruments maintained by Enfusion.

Risk and reporting

Risk tools cover what-if scenarios, live factor exposure, Greeks, DV01, implied volatility, yields, credit spreads, and post-trade factor attribution. Users can add proprietary or third-party factor models such as Axioma alongside Clearwater's GR8 model. This range suits firms that need risk views across different instruments and models rather than a single headline exposure figure.

Service and operational responsibilities

Customers receive secure, permission-based access and dedicated account-manager support, with help by phone and email. Enfusion's managed-services operation uses the same cloud-native platform and a team of more than 200 operations professionals, which may appeal to firms seeking operational support. Clients remain responsible for the hardware, software, internet bandwidth, and related equipment needed to access the service.

The terms require annual risk assessments, logical and physical access controls, documented incident response, and breach notification where feasible within 72 hours. Enfusion states that it is not a broker-dealer or investment adviser and does not provide accounting, tax, financial, investment, or legal advice; firms should not treat the platform as a substitute for those services.

Pricing

Enfusion by Clearwater: custom pricing. A demo can be requested with no commitment or contract required. The paid offering has no published tier breakdown, seat limits, or usage caps to compare, so firms should establish scope and total cost in the sales discussion rather than assume a standard package.

Because pricing is on request, Enfusion is most appropriate for organizations prepared to evaluate a tailored platform engagement. It is less suitable for buyers who need transparent per-seat costs or a self-serve plan before they can assess fit.

Platforms

Enfusion supports web access and downloads for Windows, Mac, Linux, and iOS. The range accommodates desktop and mobile access, while the firm's responsibility for hardware, software, and sufficient internet bandwidth means platform support does not remove the need for suitable client-side infrastructure.

Who it's for

Enfusion is a strong candidate for hedge funds and asset managers that need portfolio management, execution, pre-trade compliance, risk analytics, and reporting to work together across multiple strategies and instruments. Its connectivity, shared accounting database, and configurable compliance controls are particularly relevant to teams managing substantial operational complexity.

It is not the natural choice for an individual investor, a small team seeking a low-cost off-the-shelf app, or a firm that wants the software provider to supply all access equipment. The custom sales process and client-side infrastructure responsibilities call for institutional readiness.

Pros and cons

Broad investment workflow: portfolio management, native order execution, pre-trade compliance, risk analytics, and reporting sit within one platform.
Wide market reach: support for many instruments and FIX links to more than 300 liquidity sources suits firms with diverse trading activity.
Configurable controls and risk models: custom compliance rules, multiple severity levels, and proprietary or third-party factor models give specialist teams room to adapt oversight.
Custom pricing: buyers cannot compare a published price or tier structure before engaging with the vendor.
Client-supplied access setup: firms must provide suitable hardware, software, and connectivity, adding operational responsibility alongside the platform decision.

Alternatives

Consider Hatcher+ FAAST if a web-based paid product with a free trial is a better starting point. CrossVal may suit buyers who want a published entry plan: Launch costs 550.00 AED per month and includes unlimited expenses, multi-bank accounts, HoldCo and OpCo consolidation, and dedicated support; its Enterprise plan uses custom pricing. FIS Data Integrity Manager is another paid web-based option.

WealthSpectrum may be worth comparing if Android, iOS, API, web, or self-hosted platform support matters. Allvue Investment Management offers a paid web and extension-based option with custom pricing by demo request. FinFolio and Juniper Square are paid options with mobile and web platform support, while AnyVault is a paid web-based alternative.

Verdict

Choose Enfusion if your hedge fund or asset management firm needs a connected front-to-back platform for portfolio decisions, execution, compliance, risk, and reporting across varied strategies. Its breadth and market connectivity are the central reasons to consider it; look elsewhere if you require transparent pricing, a lightweight self-serve product, or provider-supplied access equipment.

	Allocare AMS	Enfusion
Platforms		iOS, Linux, macOS, Web, Windows
Asset class coverage	multi_asset_alternatives
Performance reporting	Yes	Yes
Allocation analysis	Yes
Risk analysis	Yes
Asset coverage		both
Investor reporting		Yes
Multi-currency support		Yes

Allocare AMS vs Enfusion

Allocare AMS

Enfusion